The US Food and Drug Administration (FDA) has put the emergency use authorization for blood plasma to treat Covid-19 on hold, according to a report
The US Food and Drug Administration (FDA) has put the emergency use authorization for blood plasma to treat Covid-19 on hold, according to a report